13F filer · CIK 1325083
Knoll Capital Management, LLC
MIAMI, FL · filing since Q2 2013 · last filing Sep 10, 2026
Reported value
$140.7M
$-13.1M vs prior
Positions
38
New / sold out
3 / 1
Added / reduced
3 / 1
Turnover
1.4%
buys $2.1M · sells $4.1M
Top-10 weight
66.1%
Biggest buys vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Biohaven Pharmactl Hldg Co L | +64,390 | +7.7% | +$908.5K |
| New | Abeona Therapeutics | +62,689 | – | +$356.1K |
| Added | Royal Gold Inc. | +1,450 | +19.2% | +$257.9K |
| Added | Alamos Gold Inc | +9,000 | +22.0% | +$239.0K |
| New | Centerra Gold Inc | +1,227,863 | – | +$170.3K |
| New | Orchestra BioMed Holdings | +455,128 | – | +$169.8K |
Biggest sells vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Equinox Gold Corp | -550,811 | -100.0% | $-3.8M |
| Reduced | SKEENA RES LTD CAD | -20,000 | -6.3% | $-318.4K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Aldeyra Therapeutics IncCOM | 5,475,516 | $21.0M | 14.91% |
| 2 | Biohaven Pharmactl Hldg Co LCOM | 895,269 | $12.6M | 8.98% |
| 3 | Entera Bio LtdSHS | 5,881,879 | $11.2M | 7.95% |
| 4 | SPDR Gold TrustGOLD SHS | 32,000 | $9.8M | 6.94% |
| 5 | MeiraGTX HoldingsCOM | 1,250,000 | $8.2M | 5.79% |
| 6 | Kinross Gold CorpCOM | 440,000 | $6.9M | 4.89% |
| 7 | Agnico Eagle Mines LtdCOM | 55,500 | $6.6M | 4.69% |
| 8 | Sandstorm Gold LtdCOM NEW | 700,000 | $6.6M | 4.68% |
| 9 | Avadel Pharmaceuticals PlcSPONSORED ADR | 600,000 | $5.3M | 3.78% |
| 10 | Elicio Therapeutics IncCOM | 630,915 | $4.9M | 3.46% |
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.